drugset / Trial / NCT02687256

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

NCT02687256

Phase 1 Completed 24 enrolled Stanford University Medtronic · collab
RandomizedCrossoverDouble-blindTreatment

Summary

This is a blinded cross-over study to see if extended wear insulin infusion sets can prolong insulin infusion set wear up to 7 days in adults with Type 1 Diabetes.

Timeline

Start
2016-03
Primary completion
2017-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Background Heparin Other / unclassified 40 iu
Background Heparin Other / unclassified 80 iu
Background Heparin Other / unclassified 120 iu
Background Heparin Other / unclassified 200 iu
Background Heparin Other / unclassified 400 iu